KIMBERLY JOY LAFAVE
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical ROCHESTER, NY NPI 1194473868
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$395.58
- Category: General Payments
- Program years: PY2023–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $327.91 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.96 | 6 |
| Education | $99.95 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $160.59 | 3 |
| SEAGEN INC. | $99.95 | 1 |
| Myriad Genetic Laboratories, Inc. | $40.01 | 2 |
| Merck Sharp & Dohme Corporation | $27.36 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104244681 | AstraZeneca Pharmaceuticals LP | $7.40 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104373619 | AstraZeneca Pharmaceuticals LP | $28.19 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105521559 | AstraZeneca Pharmaceuticals LP | $125.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130891828 | SEAGEN INC. | $99.95 | 10/10/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1141756876 | Merck Sharp & Dohme LLC | $27.36 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152551562 | Myriad Genetic Laboratories, Inc. | $19.63 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152551564 | Myriad Genetic Laboratories, Inc. | $20.38 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.